Concepts (303)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammaplasty | 56 | 2024 | 1239 | 3.420 |
Why?
|
Mastectomy | 32 | 2024 | 1822 | 1.370 |
Why?
|
Surgical Flaps | 28 | 2019 | 1671 | 1.200 |
Why?
|
Microsurgery | 19 | 2018 | 795 | 1.160 |
Why?
|
Sex Reassignment Surgery | 9 | 2024 | 164 | 1.060 |
Why?
|
Epigastric Arteries | 6 | 2018 | 92 | 0.690 |
Why?
|
Free Tissue Flaps | 8 | 2018 | 331 | 0.620 |
Why?
|
Nipples | 4 | 2024 | 229 | 0.530 |
Why?
|
Breast Implants | 8 | 2015 | 411 | 0.520 |
Why?
|
Tissue and Organ Harvesting | 5 | 2020 | 373 | 0.520 |
Why?
|
Thoracic Wall | 3 | 2024 | 202 | 0.480 |
Why?
|
Patient Satisfaction | 16 | 2024 | 3461 | 0.480 |
Why?
|
Oximetry | 5 | 2017 | 459 | 0.470 |
Why?
|
Breast | 9 | 2024 | 1967 | 0.470 |
Why?
|
Breast Neoplasms | 29 | 2024 | 21017 | 0.460 |
Why?
|
Postoperative Complications | 22 | 2024 | 15633 | 0.420 |
Why?
|
Cicatrix | 6 | 2024 | 798 | 0.400 |
Why?
|
Esthetics | 7 | 2024 | 330 | 0.390 |
Why?
|
Emergency Medicine | 1 | 2020 | 1198 | 0.380 |
Why?
|
Abdominal Muscles | 2 | 2010 | 169 | 0.370 |
Why?
|
Pyoderma Gangrenosum | 1 | 2010 | 84 | 0.320 |
Why?
|
Abdominal Wall | 1 | 2010 | 166 | 0.310 |
Why?
|
Integrative Medicine | 2 | 2019 | 87 | 0.300 |
Why?
|
Rectus Abdominis | 4 | 2012 | 103 | 0.290 |
Why?
|
Testosterone | 4 | 2024 | 2472 | 0.290 |
Why?
|
Umbilicus | 2 | 2017 | 36 | 0.290 |
Why?
|
Computer-Assisted Instruction | 1 | 2009 | 362 | 0.270 |
Why?
|
Abdomen | 3 | 2020 | 1128 | 0.260 |
Why?
|
Vasoconstriction | 3 | 2018 | 592 | 0.250 |
Why?
|
Device Removal | 1 | 2010 | 630 | 0.250 |
Why?
|
Fat Necrosis | 3 | 2017 | 60 | 0.240 |
Why?
|
Osteochondroma | 1 | 2004 | 44 | 0.230 |
Why?
|
Surgery, Plastic | 3 | 2019 | 643 | 0.220 |
Why?
|
Adipose Tissue | 5 | 2022 | 3312 | 0.200 |
Why?
|
Brachial Artery | 1 | 2004 | 366 | 0.200 |
Why?
|
Humerus | 1 | 2004 | 272 | 0.200 |
Why?
|
Anastomosis, Surgical | 6 | 2018 | 983 | 0.200 |
Why?
|
Aneurysm, False | 1 | 2004 | 255 | 0.190 |
Why?
|
Internship and Residency | 2 | 2020 | 5882 | 0.190 |
Why?
|
Neurotensin | 1 | 2021 | 60 | 0.190 |
Why?
|
Reoperation | 10 | 2019 | 4303 | 0.190 |
Why?
|
Breast Implantation | 2 | 2015 | 223 | 0.190 |
Why?
|
Middle Aged | 62 | 2024 | 220920 | 0.190 |
Why?
|
Therapeutic Irrigation | 1 | 2002 | 292 | 0.180 |
Why?
|
Adjuvants, Anesthesia | 1 | 2020 | 58 | 0.180 |
Why?
|
Tissue Expansion Devices | 4 | 2015 | 156 | 0.180 |
Why?
|
Atlases as Topic | 1 | 2022 | 248 | 0.180 |
Why?
|
Surgical Mesh | 1 | 2003 | 311 | 0.180 |
Why?
|
Referral and Consultation | 5 | 2019 | 3600 | 0.180 |
Why?
|
Intraoperative Complications | 2 | 2018 | 1166 | 0.180 |
Why?
|
Papaverine | 2 | 2018 | 45 | 0.180 |
Why?
|
Female | 75 | 2024 | 392686 | 0.170 |
Why?
|
Abdominal Injuries | 1 | 2003 | 360 | 0.170 |
Why?
|
Monitoring, Physiologic | 3 | 2017 | 1779 | 0.170 |
Why?
|
Retrospective Studies | 40 | 2024 | 80646 | 0.170 |
Why?
|
Internet | 3 | 2020 | 3093 | 0.170 |
Why?
|
Graft Survival | 9 | 2018 | 3820 | 0.170 |
Why?
|
Hernia, Ventral | 1 | 2003 | 218 | 0.170 |
Why?
|
Postoperative Care | 5 | 2019 | 1468 | 0.170 |
Why?
|
Ischemia | 3 | 2018 | 1883 | 0.160 |
Why?
|
Homeopathy | 1 | 2019 | 30 | 0.160 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2002 | 250 | 0.160 |
Why?
|
Nose Neoplasms | 2 | 2019 | 249 | 0.160 |
Why?
|
Adipose Tissue, White | 1 | 2022 | 365 | 0.160 |
Why?
|
Transsexualism | 1 | 2022 | 208 | 0.160 |
Why?
|
Patient Preference | 3 | 2015 | 924 | 0.150 |
Why?
|
Lipectomy | 2 | 2010 | 113 | 0.150 |
Why?
|
Decision Making | 3 | 2013 | 3929 | 0.150 |
Why?
|
Humans | 86 | 2024 | 761572 | 0.150 |
Why?
|
Adult | 48 | 2024 | 221203 | 0.150 |
Why?
|
Wounds, Gunshot | 1 | 2003 | 582 | 0.140 |
Why?
|
Breast Diseases | 1 | 2020 | 442 | 0.140 |
Why?
|
Spectroscopy, Near-Infrared | 2 | 2013 | 740 | 0.140 |
Why?
|
Lymphatic Vessels | 1 | 2021 | 358 | 0.140 |
Why?
|
Thermogenesis | 1 | 2021 | 475 | 0.140 |
Why?
|
Nitroglycerin | 1 | 2018 | 329 | 0.140 |
Why?
|
Nicardipine | 1 | 2016 | 60 | 0.140 |
Why?
|
Parasympatholytics | 1 | 2016 | 89 | 0.140 |
Why?
|
Extremities | 1 | 2002 | 867 | 0.140 |
Why?
|
Cancer Care Facilities | 2 | 2009 | 422 | 0.130 |
Why?
|
Dexmedetomidine | 1 | 2020 | 319 | 0.130 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2018 | 410 | 0.130 |
Why?
|
Mind-Body Therapies | 1 | 2019 | 279 | 0.130 |
Why?
|
Monitoring, Intraoperative | 2 | 2013 | 942 | 0.130 |
Why?
|
Mohs Surgery | 2 | 2019 | 222 | 0.130 |
Why?
|
Follow-Up Studies | 19 | 2018 | 39107 | 0.120 |
Why?
|
Metabolic Diseases | 1 | 2022 | 683 | 0.120 |
Why?
|
Vascular Surgical Procedures | 3 | 2011 | 1489 | 0.120 |
Why?
|
Occupational Diseases | 1 | 2002 | 1490 | 0.110 |
Why?
|
Drug Substitution | 1 | 2016 | 290 | 0.110 |
Why?
|
Anesthetics, Local | 1 | 2020 | 997 | 0.110 |
Why?
|
Vasodilator Agents | 1 | 2018 | 973 | 0.110 |
Why?
|
Carcinoma, Basal Cell | 1 | 2019 | 560 | 0.110 |
Why?
|
Necrosis | 5 | 2018 | 1611 | 0.110 |
Why?
|
Mammography | 1 | 2024 | 2430 | 0.110 |
Why?
|
Bombs | 1 | 2013 | 73 | 0.110 |
Why?
|
Lidocaine | 1 | 2016 | 538 | 0.110 |
Why?
|
Dexamethasone | 1 | 2020 | 1948 | 0.110 |
Why?
|
Androgens | 1 | 2020 | 1286 | 0.110 |
Why?
|
Facial Neoplasms | 1 | 2014 | 125 | 0.100 |
Why?
|
Transplantation, Autologous | 5 | 2019 | 2115 | 0.100 |
Why?
|
Treatment Outcome | 19 | 2024 | 64684 | 0.100 |
Why?
|
Microdissection | 1 | 2012 | 151 | 0.100 |
Why?
|
Continuity of Patient Care | 1 | 2019 | 1069 | 0.100 |
Why?
|
Skin Transplantation | 3 | 2019 | 1083 | 0.100 |
Why?
|
Bone Neoplasms | 1 | 2004 | 2529 | 0.100 |
Why?
|
Thinness | 1 | 2015 | 490 | 0.090 |
Why?
|
Estradiol | 1 | 2018 | 1937 | 0.090 |
Why?
|
Angiography | 1 | 2016 | 1595 | 0.090 |
Why?
|
General Surgery | 1 | 2002 | 1692 | 0.090 |
Why?
|
Silicone Gels | 1 | 2010 | 39 | 0.090 |
Why?
|
Surgical Wound Infection | 2 | 2018 | 1529 | 0.090 |
Why?
|
Logistic Models | 7 | 2018 | 13255 | 0.090 |
Why?
|
Body Mass Index | 4 | 2024 | 12954 | 0.090 |
Why?
|
Blast Injuries | 1 | 2013 | 322 | 0.090 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2018 | 1520 | 0.090 |
Why?
|
Wound Healing | 5 | 2015 | 2805 | 0.080 |
Why?
|
Rupture, Spontaneous | 1 | 2010 | 362 | 0.080 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1740 | 0.080 |
Why?
|
Aged | 28 | 2020 | 169310 | 0.080 |
Why?
|
Prosthesis Failure | 2 | 2015 | 1204 | 0.080 |
Why?
|
Preoperative Care | 2 | 2016 | 2242 | 0.080 |
Why?
|
Suction | 1 | 2010 | 266 | 0.080 |
Why?
|
Body Image | 1 | 2014 | 638 | 0.080 |
Why?
|
Endothelial Cells | 1 | 2021 | 3548 | 0.080 |
Why?
|
Microvessels | 1 | 2012 | 577 | 0.080 |
Why?
|
Dissection | 1 | 2010 | 298 | 0.080 |
Why?
|
Buttocks | 1 | 2008 | 111 | 0.080 |
Why?
|
Insulin Resistance | 1 | 2022 | 3963 | 0.070 |
Why?
|
Ectodermal Dysplasia | 1 | 2008 | 106 | 0.070 |
Why?
|
Skin Neoplasms | 2 | 2019 | 5821 | 0.070 |
Why?
|
Hyperemia | 1 | 2008 | 221 | 0.070 |
Why?
|
Education, Medical, Graduate | 1 | 2019 | 2373 | 0.070 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2011 | 732 | 0.070 |
Why?
|
Neoadjuvant Therapy | 1 | 2018 | 2827 | 0.070 |
Why?
|
Self Concept | 1 | 2012 | 1045 | 0.070 |
Why?
|
Vasoconstrictor Agents | 1 | 2010 | 654 | 0.070 |
Why?
|
Surgical Wound Dehiscence | 2 | 2008 | 212 | 0.070 |
Why?
|
Chi-Square Distribution | 4 | 2015 | 3416 | 0.060 |
Why?
|
Mastectomy, Segmental | 1 | 2011 | 955 | 0.060 |
Why?
|
Male | 21 | 2024 | 360842 | 0.060 |
Why?
|
Prednisone | 1 | 2010 | 1563 | 0.060 |
Why?
|
Administration, Topical | 2 | 2018 | 704 | 0.060 |
Why?
|
Lymph Node Excision | 1 | 2011 | 1271 | 0.060 |
Why?
|
Clinical Competence | 1 | 2020 | 4793 | 0.060 |
Why?
|
Critical Pathways | 1 | 2008 | 474 | 0.060 |
Why?
|
Health Services Accessibility | 2 | 2015 | 5440 | 0.060 |
Why?
|
Masculinity | 1 | 2024 | 17 | 0.060 |
Why?
|
Learning Curve | 2 | 2016 | 230 | 0.060 |
Why?
|
Patient Participation | 1 | 2013 | 1445 | 0.060 |
Why?
|
Depression | 1 | 2023 | 8124 | 0.060 |
Why?
|
Analysis of Variance | 3 | 2019 | 6228 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3808 | 0.060 |
Why?
|
Sex Reassignment Procedures | 1 | 2024 | 70 | 0.060 |
Why?
|
Polyglactin 910 | 1 | 2003 | 55 | 0.050 |
Why?
|
Pain Measurement | 1 | 2014 | 3551 | 0.050 |
Why?
|
Skull | 1 | 2008 | 818 | 0.050 |
Why?
|
Surgery, Computer-Assisted | 1 | 2011 | 1007 | 0.050 |
Why?
|
Program Development | 1 | 2009 | 1297 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2019 | 4026 | 0.050 |
Why?
|
Keratin-7 | 1 | 2023 | 55 | 0.050 |
Why?
|
Quality of Life | 4 | 2014 | 13367 | 0.050 |
Why?
|
Program Evaluation | 1 | 2011 | 2495 | 0.050 |
Why?
|
Cohort Studies | 7 | 2018 | 41493 | 0.050 |
Why?
|
Suture Techniques | 2 | 2008 | 769 | 0.050 |
Why?
|
Arteries | 1 | 2008 | 1123 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2011 | 9280 | 0.050 |
Why?
|
Sensation | 1 | 2024 | 337 | 0.050 |
Why?
|
Ultrasonography, Interventional | 1 | 2010 | 1496 | 0.050 |
Why?
|
Operating Rooms | 1 | 2008 | 789 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2019 | 2850 | 0.050 |
Why?
|
Oxyhemoglobins | 2 | 2013 | 211 | 0.050 |
Why?
|
Compartment Syndromes | 1 | 2003 | 159 | 0.050 |
Why?
|
Skin | 1 | 2015 | 4484 | 0.050 |
Why?
|
Laparotomy | 1 | 2003 | 457 | 0.050 |
Why?
|
Quality Improvement | 2 | 2018 | 3801 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2013 | 2491 | 0.050 |
Why?
|
Ki-67 Antigen | 1 | 2023 | 629 | 0.050 |
Why?
|
Glucocorticoids | 1 | 2010 | 2161 | 0.040 |
Why?
|
Public Opinion | 1 | 2024 | 484 | 0.040 |
Why?
|
Mice, Obese | 1 | 2021 | 420 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1152 | 0.040 |
Why?
|
Societies, Medical | 1 | 2011 | 3905 | 0.040 |
Why?
|
Mammary Arteries | 2 | 2011 | 81 | 0.040 |
Why?
|
Axilla | 2 | 2011 | 624 | 0.040 |
Why?
|
Time Factors | 7 | 2018 | 39970 | 0.040 |
Why?
|
Plants, Medicinal | 1 | 2019 | 165 | 0.040 |
Why?
|
Biopsy | 1 | 2010 | 6766 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12148 | 0.040 |
Why?
|
Recurrence | 1 | 2010 | 8466 | 0.040 |
Why?
|
Gender Identity | 1 | 2023 | 766 | 0.040 |
Why?
|
Brain Mapping | 1 | 2012 | 6635 | 0.040 |
Why?
|
Patient Care Team | 1 | 2008 | 2521 | 0.040 |
Why?
|
Intraoperative Period | 1 | 2018 | 510 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2012 | 1784 | 0.030 |
Why?
|
Hemoglobins | 2 | 2013 | 1526 | 0.030 |
Why?
|
Databases, Factual | 3 | 2018 | 7967 | 0.030 |
Why?
|
New England | 2 | 2009 | 1054 | 0.030 |
Why?
|
Risk Factors | 7 | 2018 | 74213 | 0.030 |
Why?
|
Smoking | 1 | 2012 | 9053 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2010 | 12975 | 0.030 |
Why?
|
Combined Modality Therapy | 3 | 2011 | 8528 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 9002 | 0.030 |
Why?
|
Aromatase Inhibitors | 1 | 2018 | 513 | 0.030 |
Why?
|
Orthopedic Procedures | 1 | 2004 | 1265 | 0.030 |
Why?
|
Access to Information | 1 | 2017 | 316 | 0.030 |
Why?
|
Lip Neoplasms | 1 | 2014 | 36 | 0.030 |
Why?
|
Chin | 1 | 2014 | 38 | 0.030 |
Why?
|
Cheek | 1 | 2014 | 65 | 0.030 |
Why?
|
Ear Auricle | 1 | 2014 | 31 | 0.030 |
Why?
|
Medical Records | 2 | 2009 | 1408 | 0.030 |
Why?
|
Prognosis | 3 | 2019 | 29629 | 0.030 |
Why?
|
Forehead | 1 | 2014 | 75 | 0.030 |
Why?
|
Tamoxifen | 1 | 2018 | 965 | 0.030 |
Why?
|
Risk Assessment | 5 | 2015 | 23996 | 0.030 |
Why?
|
Ear Neoplasms | 1 | 2014 | 118 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2016 | 20571 | 0.030 |
Why?
|
Nasal Septum | 1 | 2014 | 130 | 0.030 |
Why?
|
Eyelid Neoplasms | 1 | 2014 | 89 | 0.030 |
Why?
|
Adiposity | 1 | 2022 | 1879 | 0.020 |
Why?
|
Comprehension | 1 | 2017 | 621 | 0.020 |
Why?
|
Graft Rejection | 2 | 2017 | 4446 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2009 | 26127 | 0.020 |
Why?
|
Mass Casualty Incidents | 1 | 2013 | 179 | 0.020 |
Why?
|
Young Adult | 4 | 2024 | 59255 | 0.020 |
Why?
|
Multiple Trauma | 1 | 2013 | 369 | 0.020 |
Why?
|
Scalp | 1 | 2014 | 389 | 0.020 |
Why?
|
Injections, Intralesional | 1 | 2011 | 280 | 0.020 |
Why?
|
Ephedrine | 1 | 2010 | 52 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2021 | 2882 | 0.020 |
Why?
|
Mastectomy, Modified Radical | 1 | 2009 | 62 | 0.020 |
Why?
|
Length of Stay | 2 | 2017 | 6426 | 0.020 |
Why?
|
Phenylephrine | 1 | 2010 | 293 | 0.020 |
Why?
|
Prospective Studies | 4 | 2017 | 54426 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3514 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2016 | 1264 | 0.020 |
Why?
|
Sepsis | 1 | 2003 | 2585 | 0.020 |
Why?
|
Algorithms | 1 | 2010 | 14032 | 0.020 |
Why?
|
Neck | 1 | 2014 | 734 | 0.020 |
Why?
|
Pilot Projects | 2 | 2013 | 8633 | 0.020 |
Why?
|
Observer Variation | 1 | 2015 | 2606 | 0.020 |
Why?
|
Anxiety | 1 | 2023 | 4573 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2014 | 970 | 0.020 |
Why?
|
Patient Care Planning | 1 | 2014 | 909 | 0.020 |
Why?
|
Seroma | 1 | 2008 | 75 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12059 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2015 | 2115 | 0.020 |
Why?
|
Health Status | 2 | 2013 | 4077 | 0.020 |
Why?
|
Trauma Centers | 1 | 2013 | 937 | 0.020 |
Why?
|
Disease Management | 1 | 2018 | 2508 | 0.020 |
Why?
|
Hernia, Abdominal | 1 | 2008 | 56 | 0.020 |
Why?
|
Carcinoma, Ductal | 1 | 2008 | 97 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 58986 | 0.020 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2008 | 231 | 0.020 |
Why?
|
Sampling Studies | 1 | 2008 | 615 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3688 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2012 | 1668 | 0.020 |
Why?
|
Triage | 1 | 2013 | 986 | 0.020 |
Why?
|
Obesity | 2 | 2022 | 12947 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14416 | 0.020 |
Why?
|
Brain | 1 | 2012 | 27120 | 0.020 |
Why?
|
Lower Extremity | 1 | 2013 | 1202 | 0.020 |
Why?
|
Gastrointestinal Tract | 1 | 2011 | 833 | 0.020 |
Why?
|
Age Distribution | 1 | 2011 | 2880 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 36429 | 0.020 |
Why?
|
Demography | 1 | 2010 | 1648 | 0.020 |
Why?
|
Venous Thromboembolism | 1 | 2018 | 1866 | 0.020 |
Why?
|
Ultrasonography | 2 | 2008 | 5972 | 0.020 |
Why?
|
Mice | 2 | 2022 | 81533 | 0.010 |
Why?
|
United States | 3 | 2019 | 72335 | 0.010 |
Why?
|
Efficiency, Organizational | 1 | 2008 | 695 | 0.010 |
Why?
|
Reference Values | 1 | 2011 | 4920 | 0.010 |
Why?
|
Data Collection | 1 | 2013 | 3322 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12725 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2017 | 3744 | 0.010 |
Why?
|
Overweight | 1 | 2015 | 2417 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2017 | 12341 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2011 | 1685 | 0.010 |
Why?
|
Health Education | 1 | 2010 | 1052 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2011 | 2915 | 0.010 |
Why?
|
Collagen | 1 | 2011 | 2638 | 0.010 |
Why?
|
Equipment Design | 1 | 2011 | 3511 | 0.010 |
Why?
|
Incidence | 2 | 2012 | 21355 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2011 | 20099 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2010 | 2426 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22172 | 0.010 |
Why?
|
Animals | 3 | 2022 | 168467 | 0.010 |
Why?
|
Carcinoma in Situ | 1 | 2008 | 791 | 0.010 |
Why?
|
Hospital Costs | 1 | 2008 | 947 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2010 | 22176 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15732 | 0.010 |
Why?
|
Oxygen | 1 | 2013 | 4227 | 0.010 |
Why?
|
Homeostasis | 1 | 2012 | 3323 | 0.010 |
Why?
|
Swine | 1 | 2011 | 5915 | 0.010 |
Why?
|
Boston | 1 | 2013 | 9326 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2011 | 2759 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2013 | 3249 | 0.010 |
Why?
|
Carcinoma | 1 | 2011 | 2330 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23447 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2011 | 11121 | 0.010 |
Why?
|
Liver | 1 | 2011 | 7529 | 0.010 |
Why?
|
Age Factors | 1 | 2011 | 18398 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2008 | 26198 | 0.000 |
Why?
|
Concepts
(303)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(46)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_